Human Papillomavirus (HPV)
FDA Approves New Vaccine Effective Against 9 Types of Human Papillomavirus
- Details
- Category: Anal & Cervical Cancer
- Published on Tuesday, 09 December 2014 00:00
- Written by WHO
The U.S. Food and Drug Administration this week approved a new "9-valent" human papillomavirus (HPV) vaccine from Merck that protects against infection with more high-risk or cancer-causing strains. The new Gardasil 9 vaccine is expected to prevent about 90% of cervical, anal, and genital cancers. The vaccine is approved for young women ages 9-26 and young men ages 9-15.
ICAAC 2014: Anal HPV Infection and Dysplasia Common in HIV+ Women and Gay Men
- Details
- Category: Human Papillomavirus (HPV)
- Published on Friday, 03 October 2014 00:00
- Written by Liz Highleyman
Anal infection with high-risk human papillomavirus (HPV) types was common among women with HIV in France, while a Spanish study found a low rate of pre-cancerous anal cell changes in HIV positive women compared with men who have sex with men, researchers reported at the recent 54th Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, DC.
Human Papillomavirus Vaccine Is Effective for Women with HIV
- Details
- Category: Women & HIV
- Published on Tuesday, 06 May 2014 00:00
- Written by Liz Highleyman
HIV positive women respond well to the Gardasil human papillomavirus (HPV) vaccine, offering them protection against cervical cancer, according to a study published in the April 14 electronic edition of Clinical Infectious Diseases. Related recent research found that both Gardasil and Cervarix are effective in people with HIV.
AIDS 2014: Young People with HIV Respond Well to Human Papillomavirus Vaccine
- Details
- Category: HPV Vaccines
- Published on Tuesday, 29 July 2014 00:00
- Written by Liz Highleyman
The quadrivalent human papillomavirus (HPV) vaccine worked as well for teens and young adults with HIV as it did for their HIV negative counterparts, according to study findings presented the 20thInternational AIDS Conference last week in Melbourne.
FDA Approves HPV DNA Test as Pap Smear Alternative for Cervical Cancer Screening
- Details
- Category: Human Papillomavirus (HPV)
- Published on Tuesday, 29 April 2014 00:00
- Written by FDA
The U.S. Food and Drug Administration (FDA) last week approved Roche Diagnostics' cobas human papillomavirus (HPV DNA test for initial screening for cervical cancer. The test detects high-risk or cancer-causing HPV types including HPV-16 and HPV-18. Women who test positive for high-risk HPV can then undergo further testing for pre-cancerous or malignant cell changes.
More Articles...
- CROI 2014: Natural History of HIV-Related Anal Dysplasia [VIDEO]
- Black Women More Likely to Carry Human Papillomavirus Strains Not Covered by Vaccines
- EACS 2013: Ensuring Good Quality HIV Care in Europe: Where Can We Improve?
- EACS 2013: Anal Cancer Screening May Be Appropriate for All Women with HIV
Web Design and Development by